Core Viewpoint - Syra Health Corp. has announced its intention to voluntarily delist its common stock from the Nasdaq Capital Market to focus on strengthening its core fundamentals and reducing costs associated with the listing [1][3]. Delisting Process - The company plans to file a Form 25 with the SEC around April 11, 2025, with the delisting taking effect no earlier than ten days thereafter, expecting the last trading day on Nasdaq to be around April 21, 2025 [2]. - The delisting decision follows a notice from Nasdaq indicating that the company's stock price had been below the minimum requirement of $1.00 per share for 30 consecutive business days [4]. Strategic Focus - The management believes that this strategic pause will enhance operational efficiencies, optimize financial health, and generate sustainable long-term growth [3]. - The company will continue to provide information to shareholders and facilitate trading on the OTC market until it decides to reapply for a national securities exchange listing [5]. Company Overview - Syra Health is a healthcare technology company focused on improving health in areas such as mental health, population health, and the healthcare workforce through innovative technology products and services [6].
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market